Indira Brar
- Infectious Diseases top 1%
- Virology top 1%
- Emergency Medicine top 2%
- Epidemiology top 10%
- Neurology top 5%
- Co-authors
- Hal MartinGeehan SuleymanRaef FadelGeorge AlangadenCarina DagherZachary DemertzisKelly MaletteMayur Ramesh
- Topics
- HIV/AIDS drug development and treatment (18 papers)HIV Research and Treatment (13 papers)COVID-19 Clinical Research Studies (11 papers)
- Journals
- The LancetSHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Indira Brar
48 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Infectious Diseases 1.1k
- Virology 449
- Emergency Medicine 361
- Epidemiology 330
- Neurology 238
Countries citing papers authored by Indira Brar
This map shows the geographic impact of Indira Brar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indira Brar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indira Brar more than expected).
Fields of papers citing papers by Indira Brar
This network shows the impact of papers produced by Indira Brar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indira Brar. The network helps show where Indira Brar may publish in the future.
Co-authorship network of co-authors of Indira Brar
This figure shows the co-authorship network connecting the top 25 collaborators of Indira Brar. A scholar is included among the top collaborators of Indira Brar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Indira Brar. Indira Brar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 0 | |
| 8 | 4 | |
| 9 | 0 | |
| 10 | 1 | |
| 11 | Seroprevalence of antibodies against sars-cov-2 among people living with hiv (PLWH) | 1 |
| 12 | 25 | |
| 13 | 3 | |
| 14 | Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trialbreakdown → | 257 |
| 15 | 165 | |
| 16 | 11 | |
| 17 | 3 | |
| 18 | 1 | |
| 19 | 24 | |
| 20 | 144 |
About Indira Brar
Indira Brar is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 56 papers that have together received 1.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (13 papers) and COVID-19 Clinical Research Studies (11 papers). The work is most often cited by research in Virology (449 citations), Infectious Diseases (1.1k citations) and Emergency Medicine (361 citations). Indira Brar has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Hal Martin, Geehan Suleyman, Raef Fadel, George Alangaden, Carina Dagher, Zachary Demertzis, Kelly Malette, Mayur Ramesh, Joseph Miller and Marcus Zervos. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.